drugset / Trial / NCT00857090

Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones

NCT00857090 ↗

Phase 1/2 Completed 18 enrolled Omeros Corporation
RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of the study are to assess the systemic exposure, safety and efficacy of three concentrations of OMS201 in subjects undergoing retrograde ureteroscopic removal of upper urinary tract stones.

Timeline

Start
2009-03
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject OMS201 Unknown — Other

Indications